Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Blair William & Co. IL

Key Points

• Blair William & Co. IL increased its stake in Intuitive Surgical, raising its ownership to approximately 0.13%, valued at $234.47 million.
• Insider trading activity showed significant stock sales, with SVP Mark Brosius and EVP Myriam Curet selling shares that reduced their holdings by 19.23% and 92.73%, respectively.
• Analysts have a favorable outlook on Intuitive Surgical with many maintaining a "buy" rating, and the stock has an average price target of $595.95.

Blair William & Co. IL lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.0% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 473,416 shares of the medical equipment provider's stock after buying an additional 4,536 shares during the quarter. Blair William & Co. IL owned approximately 0.13% of Intuitive Surgical worth $234,469,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of ISRG. Heritage Trust Co boosted its position in shares of Intuitive Surgical by 31.1% in the first quarter. Heritage Trust Co now owns 2,303 shares of the medical equipment provider's stock worth $1,141,000 after purchasing an additional 546 shares during the period. Argent Trust Co lifted its stake in shares of Intuitive Surgical by 0.4% in the 1st quarter. Argent Trust Co now owns 10,260 shares of the medical equipment provider's stock valued at $5,081,000 after purchasing an additional 39 shares during the last quarter. Blue Sky Capital Consultants Group Inc. boosted its stake in Intuitive Surgical by 770.8% during the first quarter. Blue Sky Capital Consultants Group Inc. now owns 5,704 shares of the medical equipment provider's stock worth $2,825,000 after buying an additional 5,049 shares during the period. Scotia Capital Inc. boosted its stake in shares of Intuitive Surgical by 1.6% during the 1st quarter. Scotia Capital Inc. now owns 5,251 shares of the medical equipment provider's stock worth $2,601,000 after purchasing an additional 85 shares during the period. Finally, Liberty Wealth Management LLC lifted its stake in Intuitive Surgical by 685.3% in the first quarter. Liberty Wealth Management LLC now owns 77,638 shares of the medical equipment provider's stock worth $38,452,000 after purchasing an additional 67,752 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Intuitive Surgical

In other news, SVP Mark Brosius sold 216 shares of the firm's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $563.11, for a total transaction of $121,631.76. Following the completion of the transaction, the senior vice president directly owned 907 shares in the company, valued at $510,740.77. This trade represents a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 15,903 shares of company stock valued at $7,932,778. Corporate insiders own 0.70% of the company's stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded down $9.27 during trading on Thursday, reaching $464.80. 614,725 shares of the stock traded hands, compared to its average volume of 2,003,950. The company has a market capitalization of $166.62 billion, a price-to-earnings ratio of 64.87, a P/E/G ratio of 5.00 and a beta of 1.59. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The business has a fifty day simple moving average of $519.86 and a two-hundred day simple moving average of $531.12.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The firm had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. During the same quarter last year, the firm earned $1.78 EPS. The business's quarterly revenue was up 21.4% on a year-over-year basis. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft lowered Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their price objective for the stock from $515.00 to $440.00 in a research note on Monday, June 9th. Piper Sandler reiterated an "overweight" rating and issued a $595.00 price objective (up previously from $575.00) on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Royal Bank Of Canada increased their target price on shares of Intuitive Surgical from $605.00 to $615.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 23rd. Finally, BTIG Research boosted their price target on Intuitive Surgical from $566.00 to $571.00 and gave the stock a "buy" rating in a research note on Wednesday, July 23rd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.